Related Experiment Video

Updated: Apr 15, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.2K

High expression of small GTPase Rab3D promotes cancer progression and metastasis

Jian Yang1,2,3, Wei Liu1,2,3, Xin'an Lu1,2,3

  • 1National Engineering Laboratory for Anti-tumor Protein Therapeutics, Tsinghua University, Beijing, China.

Oncotarget
|April 1, 2015
PubMed

Insights

Rab3D, a secretory small GTPase, drives cancer metastasis by promoting tumor invasion and migration. Blocking Rab3D function offers a potential therapeutic strategy against cancer spread.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Rab GTPases regulate membrane trafficking, including exosome release.
  • Rab3D is a key regulator of protein secretion.
  • The role of Rab3D in cancer, particularly metastasis, remains largely uncharacterized.

Purpose of the Study:

  • To investigate the function and molecular mechanisms of Rab3D in cancer progression and metastasis.
  • To assess Rab3D expression levels in various cancer types and clinical specimens.

Main Methods:

  • Quantification of Rab3D protein levels in cancer cell lines and clinical samples.
  • Establishment of in vitro migration and in vivo orthotopic metastatic mouse models.
  • Analysis of AKT/GSK3β signaling pathway activation and epithelial-mesenchymal transition (EMT) induction.
  • Assessment of extracellular Heat Shock Protein 90 alpha (Hsp90α) secretion.

Main Results:

  • Rab3D expression is dysregulated in cancer cells and correlates with tumor malignancy.
  • Increased Rab3D expression enhances tumor invasion and lung metastasis in vivo.
  • Rab3D knockdown inhibits tumor cell motility.
  • Rab3D activates AKT/GSK3β signaling, promoting EMT and Hsp90α secretion, thereby driving migration and invasion.

Conclusions:

  • Rab3D is a critical regulator of cancer metastasis.
  • Targeting Rab3D represents a potential therapeutic avenue for inhibiting cancer spread.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.5K